# The Effects of Sevelamer Carbonate on Diabetic Nephropathy

> **NCT01493050** · PHASE2 · COMPLETED · sponsor: **Gary Striker** · enrollment: 117 (actual)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** Sevelamer Carbonate
- **DRUG:** calcium carbonate

## Key facts

- **NCT ID:** NCT01493050
- **Lead sponsor:** Gary Striker
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2014-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01493050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01493050, "The Effects of Sevelamer Carbonate on Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01493050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*